Geoffrey W. McCaughan

29.9k total citations · 3 hit papers
528 papers, 20.3k citations indexed

About

Geoffrey W. McCaughan is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Geoffrey W. McCaughan has authored 528 papers receiving a total of 20.3k indexed citations (citations by other indexed papers that have themselves been cited), including 286 papers in Hepatology, 216 papers in Epidemiology and 187 papers in Surgery. Recurrent topics in Geoffrey W. McCaughan's work include Liver Disease Diagnosis and Treatment (169 papers), Liver Disease and Transplantation (136 papers) and Organ Transplantation Techniques and Outcomes (136 papers). Geoffrey W. McCaughan is often cited by papers focused on Liver Disease Diagnosis and Treatment (169 papers), Liver Disease and Transplantation (136 papers) and Organ Transplantation Techniques and Outcomes (136 papers). Geoffrey W. McCaughan collaborates with scholars based in Australia, United States and New Zealand. Geoffrey W. McCaughan's co-authors include Mark D. Gorrell, David G. Bowen, Patrick Bertolino, Paul Haber, G. Alex Bishop, Catherine A. Abbott, Simone I. Strasser, Jeremy S. Wilson, Minoti V. Apte and Romano C. Pirola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Geoffrey W. McCaughan

512 papers receiving 19.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture

1998 738 citations Geoffrey W. McCaughan et al. profile →
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression

2003 582 citations James G. Kench, Geoffrey W. McCaughan et al. profile →
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

2021 331 citations Martin Weltman, Geoffrey W. McCaughan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geoffrey W. McCaughan Australia	73	8.7k	8.4k	5.2k	4.7k	3.4k	528	20.3k
Jesús Prìeto Spain	82	7.9k 0.9×	6.8k 0.8×	3.4k 0.7×	6.0k 1.3×	5.0k 1.5×	606	24.6k
Satoru Todo Japan	73	6.9k 0.8×	3.2k 0.4×	10.6k 2.0×	2.9k 0.6×	2.5k 0.7×	570	20.3k
Anthony J. Demetris United States	81	8.4k 1.0×	5.3k 0.6×	11.0k 2.1×	3.0k 0.6×	3.7k 1.1×	379	23.3k
Tania Roskams Belgium	83	11.6k 1.3×	8.5k 1.0×	8.3k 1.6×	4.7k 1.0×	1.7k 0.5×	428	25.9k
Tsutomu Chiba Japan	78	2.6k 0.3×	4.4k 0.5×	8.7k 1.7×	4.5k 1.0×	4.2k 1.2×	603	24.2k
Étienne Sokal Belgium	67	6.5k 0.7×	5.0k 0.6×	7.0k 1.4×	3.0k 0.6×	773 0.2×	420	15.2k
Swan N. Thung United States	69	7.5k 0.9×	6.4k 0.8×	4.3k 0.8×	2.9k 0.6×	1.2k 0.3×	320	17.0k
Giuliano Ramadori Germany	59	4.9k 0.6×	4.0k 0.5×	2.7k 0.5×	1.4k 0.3×	1.6k 0.5×	375	12.3k
John P. Iredale United Kingdom	72	11.0k 1.3×	8.7k 1.0×	5.1k 1.0×	2.2k 0.5×	3.9k 1.1×	176	21.3k
Luciano Adorini Italy	80	1.6k 0.2×	4.4k 0.5×	3.0k 0.6×	4.3k 0.9×	10.8k 3.2×	338	24.8k

Countries citing papers authored by Geoffrey W. McCaughan

Since Specialization

Citations

This map shows the geographic impact of Geoffrey W. McCaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey W. McCaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey W. McCaughan more than expected).

Fields of papers citing papers by Geoffrey W. McCaughan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey W. McCaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey W. McCaughan. The network helps show where Geoffrey W. McCaughan may publish in the future.

Co-authorship network of co-authors of Geoffrey W. McCaughan

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey W. McCaughan. A scholar is included among the top collaborators of Geoffrey W. McCaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey W. McCaughan. Geoffrey W. McCaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prince, David, David Baker, Ken Liu, et al.. (2024). Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance. Journal of Gastroenterology and Hepatology. 40(1). 250–257. 1 indexed citations

Marsh‐Wakefield, Felix, Angela L. Ferguson, Thomas M. Ashhurst, et al.. (2024). Spatial mapping of the HCC landscape identifies unique intratumoral perivascular-immune neighborhoods. Hepatology Communications. 8(11). 2 indexed citations

Fink, Michael, Paul Gow, Geoffrey W. McCaughan, et al.. (2023). Impact of Share 35 liver transplantation allocation in Australia and New Zealand. Clinical Transplantation. 38(1). e15203–e15203.

Dennis, Claude V., Marti Cabanes‐Creus, Chuanmin Wang, et al.. (2023). Liver splitting during normothermic machine perfusion: a novel method to combine the advantages of both in-situ and ex-vivo techniques. HPB. 25(5). 543–555. 18 indexed citations

Liu, Ken, et al.. (2023). Indocyanine green: A novel marker for assessment of graft quality during ex situ normothermic machine perfusion of human livers. Artificial Organs. 48(5). 472–483. 5 indexed citations

Cholan, Pradeep Manuneedhi, et al.. (2021). Transplantation of high fat fed mouse microbiota into zebrafish larvae identifies MyD88‐dependent acceleration of hyperlipidaemia by Gram‐positive cell wall components. BioFactors. 48(2). 329–341. 4 indexed citations

Jeffrey, Gary P., Michael Stormon, Gordon Thomas, et al.. (2020). Outcomes for children after second liver transplantations are similar to those after first transplantations: a binational registry analysis. The Medical Journal of Australia. 213(10). 464–470. 3 indexed citations

Liu, Ken, Jinbiao Chen, & Geoffrey W. McCaughan. (2020). Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases. Hepatoma Research. 2020. 6 indexed citations

Zhao, Yang, Ka Ka Ting, Jia Li, et al.. (2017). Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy. Cancer Research. 77(16). 4434–4447. 50 indexed citations

10.

Gogoi-Tiwari, Jully, Corey Giles, Dirk Schmidt‐Arras, et al.. (2017). The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury. Journal of Visualized Experiments. 12 indexed citations

11.

Prakoso, Emilia, Janina E. E. Tirnitz‐Parker, Andrew D. Clouston, et al.. (2014). Analysis of The Intrahepatic Ductular Reaction and Progenitor Cell Responses in Hepatitis C Virus Recurrence After Liver Transplantation. Liver Transplantation. 20(12). 1508–1519. 24 indexed citations

12.

Sharbeen, George, et al.. (2011). A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling. Molecular Cancer Research. 9(7). 948–959. 50 indexed citations

13.

Sievert, William, G.J. Dore, Geoffrey W. McCaughan, et al.. (2009). SIGNIFICANT HEMOGLOBIN (HB) DECLINE DURING PEGYLATED INTERFERON AND RIBAVIRIN THERAPY IN HCV GENOTYPE 1 IS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR): AN ANALYSIS FROM THE CHARIOT STUDY. Hepatology. 50(4). 1 indexed citations

14.

Gorrell, Mark D., Catherine A. Abbott, Thilo Kähne, et al.. (2006). Relating Structure to Function in the Beta-Propeller Domain of Dipeptidyl Peptidase IV. Kluwer Academic Publishers eBooks. 477. 89–95. 3 indexed citations

15.

Crawford, Dorothy H., Linda Fletcher, Stefan G. Hübscher, et al.. (2004). Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology. 39(6). 1655–1662. 55 indexed citations

16.

Crawford, Dorothy H., S.G. Hübscher, Katherine Stuart, et al.. (2002). Hereditary hemochromatosis and liver transplantation: Implications for patient survival, graft function and the pathogenesis of hereditary hemochromatosis.. Hepatology. 36(4). 2 indexed citations

17.

Heydtmann, Mathis, Philip Shields, Geoffrey W. McCaughan, & David Adams. (2001). Cytokines and chemokines in the immune response to hepatitis C infection. Current Opinion in Infectious Diseases. 14(3). 279–287. 44 indexed citations

18.

Farrell, GC, Y‐F Liaw, & Geoffrey W. McCaughan. (2000). JGH and Asia–Pacific consensus on prevention and management of gastrointestinal and liver diseases. Journal of Gastroenterology and Hepatology. 15(8). 815–818. 27 indexed citations

19.

Rao, A.R., A. Chui, Liwei Shi, et al.. (2000). Orthotopic liver transplantation for treatment of patients with Budd–Chiari syndrome: a singe-center experience. Transplantation Proceedings. 32(7). 2206–2207. 12 indexed citations

20.

McCaughan, Geoffrey W., et al.. (1989). DANAZOL AND HEPATIC NEOPLASIA: A CASE REPORT. Australian and New Zealand Journal of Medicine. 19(6). 733–735. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact